Literature DB >> 11558259

[Structural-functional study of recombinant forms of onconase].

I I Vorob'ev1, N A Ponomarenko, O M Durova, A V Kozyr', A V Demin, A V Kolesnikov, L P Sashchenko, M Ia Karpeĭskiĭ, A G Gabibov.   

Abstract

A method for expression of an onconase gene leading to a soluble form of the protein was developed. The enzymatic and cytotoxic properties of the protein's recombinant forms were studied. Recombinant onconase with an additional N-terminal Met residue isolated in nondenaturing conditions did not substantially differ from the native enzyme in ribonucleolytic activity. The addition of a 33-mer peptide containing auxiliary elements for the simplification of isolation and detection of the recombinant protein did not affect the enzyme properties of onconase. The method proposed is useful for the onconase structure-function relation studies and enables construction of onconase-based fusion proteins for anticancer therapy.

Mesh:

Substances:

Year:  2001        PMID: 11558259

Source DB:  PubMed          Journal:  Bioorg Khim        ISSN: 0132-3423


  1 in total

1.  Design of targeted B cell killing agents.

Authors:  Alexey V Stepanov; Alexey A Belogurov; Natalia A Ponomarenko; Oleg A Stremovskiy; Leonid V Kozlov; Anna M Bichucher; Sergey E Dmitriev; Ivan V Smirnov; Olga G Shamborant; Dmitry S Balabashin; Lidia P Sashchenko; Alexander G Tonevitsky; Alain Friboulet; Alexander G Gabibov; Sergey M Deyev
Journal:  PLoS One       Date:  2011-06-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.